根治性前列腺切除术后前列腺内PSMA最大标准化摄取值的影响:系统评价与荟萃分析
本系统评价与荟萃分析纳入23项研究,评估术前前列腺特异性膜抗原(PSMA)正电子发射断层扫描(PET)所测优势前列腺病灶最大标准化摄取值(SUVmax)与根治性前列腺切除术后国际泌尿病理学会(ISUP)分级分组、病理肿瘤(pT)分期及生化复发(BCR)的关系。汇总SUVmax随ISUP分级分组升高而单调增加,pT3/4期高于pT2期,但所有亚组异质性均较大(I²>50%)。作者认为不推荐使用单一SUVmax阈值进行临床决策。
要点
- 汇总SUVmax随ISUP分级分组升高而单调增加,从ISUP 1级的5.8(95%CI 3.9-7.7)升至ISUP 5级的17.3(95%CI 13.1-21.5)。
- pT3/4期汇总SUVmax为13.8(95%CI 10.9-16.7),高于pT2期的9.7(95%CI 7.8-11.5)。
- 作者认为不推荐使用单一SUVmax阈值进行临床决策,因研究间变异性高。
核心结论
- 术前前列腺内PSMA SUVmax随ISUP分级分组和病理肿瘤分期升高而单调增加,较高的SUVmax与无生化复发生存期缩短相关,但不推荐使用单一SUVmax阈值进行临床决策,因研究间变异性高。
研究设计与样本
- 遵循PRISMA指南的系统评价与荟萃分析,检索数字图书馆和数据库,纳入23项报告PSMA PET CT或MRI所测SUVmax及后续根治性前列腺切除术后ISUP分级分组、pT分期和BCR的研究;使用QUADAS-2和PROBAST工具进行质量评估;采用随机效应荟萃分析和荟萃回归;研究注册于PROSPERO(CRD42023408170)。
主要发现
- 汇总SUVmax随ISUP分级分组升高而单调增加:ISUP 1级为5.8(95%CI 3.9-7.7),至ISUP 5级为17.3(95%CI 13.1-21.5)。
- pT2期汇总SUVmax为9.7(95%CI 7.8-11.5),pT3/4期增至13.8(95%CI 10.9-16.7)。
- 所有亚组均存在较大异质性(I²>50%),仅限使用[68Ga]Ga-PSMA-11的研究进行分析未能减轻异质性。
- 6篇报告BCR的论文叙述性合成显示,SUVmax升高与至BCR时间缩短相关。
关键数值与推荐
- ISUP 1级汇总SUVmax为5.8(95%CI 3.9-7.7),ISUP 5级为17.3(95%CI 13.1-21.5)。
- pT2期汇总SUVmax为9.7(95%CI 7.8-11.5),pT3/4期为13.8(95%CI 10.9-16.7)。
- 所有亚组异质性I²>50%。
临床怎么用
- 作者认为不推荐使用单一SUVmax阈值进行临床决策,因研究间变异性高。
局限性
- 所有亚组均存在较大异质性(I²>50%),仅限使用[68Ga]Ga-PSMA-11的研究进行分析未能减轻异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To perform a systematic review and meta-analysis to assess the relationship between intraprostatic maximum standardised uptake value (SUVmax) of the dominant prostatic lesion as measured on preoperative prostate-specific membrane antigen (PSMA) positron emission tomography (PET) with radical prostatectomy International Society of Urological Pathology (ISUP) Grade Group, pathological tumour (pT) staging, and biochemical recurrence (BCR). METHODS: Prostate-specific membrane antigen PET may offer non-invasive assessment of histopathological and oncological outcomes before definitive treatment. SUVmax of the dominant lesion has been explored as a prognostic biomarker. Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, we performed reviews of digital libraries and databases and retrieved studies reporting SUVmax quantified on PSMA PET computed tomography or magnetic resonance imaging and subsequent radical prostatectomy ISUP Grade Group, pT stage, and BCR. Quality assessment was performed using Quality Assessment of Diagnostic Accuracy Studies-2 and Prediction model Risk of Bias Assessment tools. Random effects meta-analysis and meta-regression by ISUP Grade Group and pT2 vs pT3/4 stage was performed. This study was registered on the International Prospective Register of Systematic Reviews (PROSPERO: CRD42023408170). EVIDENCE SYNTHESIS: After removing duplicates, 23 studies were included for review. Pooled SUVmax (95% confidence interval [CI]) increased monotonically with advancing ISUP Grade Group, with ISUP 1: 5.8 (95% CI 3.9-7.7), through to ISUP 5: 17.3 (95% CI 13.1-21.5). For pT2 disease, pooled SUVmax: 9.7 (95% CI 7.8-11.5) increasing to 13.8 (95% CI 10.9-16.7) for pT3/4 disease. Substantial inconsistency was noted (I2 >50%) for all subgroups. This was not attenuated by restricting analysis only to studies using [68Ga]Ga-PSMA-11. Narrative synthesis of six papers reporting BCR showed increasing SUVmax was associated with reduced time to BCR. CONCLUSION: Preoperative intraprostatic PSMA SUVmax increases monotonically with higher ISUP Grade Group and pathological tumour stage. Higher SUVmax is associated with reduced BCR-free survival. However, the use of single SUVmax thresholds for clinical decision making is not recommended as variability between studies is high.
引用
- Chen DC, Huang S, Papa N, et al. Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta-analysis. BJU Int. 2025. PMID: 39763428. doi:10.1111/bju.16608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。